Kangmei Pharmaceutical Co Ltd (600518) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:Asia

Author(s):

Product Code:GDPH197245D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

36

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Kangmei products include Chinese herbal medicine, bottled single product, hong mei life, xinkaihe senate, chinese medicine derived, medicine, chemical drugs and ju huang tea among others. It provides chemical drugs such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, and paracetamol and pseudoephedrine hydrochloride tablets. The company also offers Xinkaihe warm tea, Ginkgo thirty-seven hawthorn polyphenol capsules, Propolis, McKinley card Calcium Iron zinc and selenium chewable tablets, and Happiness red Luzhou nourishing Okuma. It operates in Beijing, Shanghai and Hong Kong. Kangmei is headquartered in Shenzhen, Guangdong, China.

Kangmei Pharmaceutical Co Ltd (600518)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Kangmei Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Kangmei Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Kangmei Pharma To Acquire Three Hospitals In China For USD 82 Million 12

Venture Financing 13

Twist Bioscience Raises Additional USD27 Million in Venture Financing 13

Partnerships 15

Kangmei Pharma Enters into Agreement with BGI Genomics 15

Equity Offering 16

Kangmei Pharma Raises USD1.3 Billion in Private Placement of Shares 16

Kangmei Pharma Plans For Private Placement Of Shares For USD972.4 Million 17

Debt Offering 18

Kangmei Pharma Raises USD154 Million in Public Offering of 7% Notes Due 2021 18

Kangmei Pharma Plans to Raise USD159.21 Million in Public Offering of Bonds 19

Kangmei Pharma Raises USD236.9 Million in Public Offering of 5.38% 2018 First Tranche Notes Due 2018 20

Kangmei Pharma Raises USD454.1 Million in Private Placement of Bonds 21

Kangmei Pharma Raises USD304.7 Million in Public Offering of Third Tranche of 5.47% Notes Due 2022 22

Kangmei Pharma Raises USD300 Million in Public Offering of Second Tranche of 5.29% Notes Due 2022 23

Kangmei Pharma to Raise USD1.6 Billion in Public Offering of Notes 24

Kangmei Pharma Raises USD220.3 Million in Public Offering of Debentures 25

Kangmei Pharma Raises USD369 Million in First Tranche of Public Offering of 3.28% Debentures Due 2017 26

Kangmei Pharma to Raise up to USD391 Million in Private Placement of Bonds 27

Acquisition 28

Kangmei Pharma to Acquire 80% Stake in Huizhou-Based Pharmaceutical Company for USD3.18 million 28

Kangmei Pharma Plans to Acquire Pharmaceutical Company for USD21 Million 29

Kangmei Pharma to Acquire Chongqing Ruitai Pharma for USD12.5 Million 30

Kangmei Pharma to Acquire 80% Stake in Guangdong Xin'ao Pharma for USD9 Million 31

Kangmei Pharma to Acquire Shenzhen Ieman Pharma for USD3.5 Million 32

Kangmei Pharmaceutical Co Ltd-Key Competitors 33

Kangmei Pharmaceutical Co Ltd-Key Employees 34

Kangmei Pharmaceutical Co Ltd-Locations And Subsidiaries 35

Head Office 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List of Figure

List of Figures

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Kangmei Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List of Table

List of Tables

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Kangmei Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Kangmei Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kangmei Pharma To Acquire Three Hospitals In China For USD 82 Million 12

Twist Bioscience Raises Additional USD27 Million in Venture Financing 13

Kangmei Pharma Enters into Agreement with BGI Genomics 15

Kangmei Pharma Raises USD1.3 Billion in Private Placement of Shares 16

Kangmei Pharma Plans For Private Placement Of Shares For USD972.4 Million 17

Kangmei Pharma Raises USD154 Million in Public Offering of 7% Notes Due 2021 18

Kangmei Pharma Plans to Raise USD159.21 Million in Public Offering of Bonds 19

Kangmei Pharma Raises USD236.9 Million in Public Offering of 5.38% 2018 First Tranche Notes Due 2018 20

Kangmei Pharma Raises USD454.1 Million in Private Placement of Bonds 21

Kangmei Pharma Raises USD304.7 Million in Public Offering of Third Tranche of 5.47% Notes Due 2022 22

Kangmei Pharma Raises USD300 Million in Public Offering of Second Tranche of 5.29% Notes Due 2022 23

Kangmei Pharma to Raise USD1.6 Billion in Public Offering of Notes 24

Kangmei Pharma Raises USD220.3 Million in Public Offering of Debentures 25

Kangmei Pharma Raises USD369 Million in First Tranche of Public Offering of 3.28% Debentures Due 2017 26

Kangmei Pharma to Raise up to USD391 Million in Private Placement of Bonds 27

Kangmei Pharma to Acquire 80% Stake in Huizhou-Based Pharmaceutical Company for USD3.18 million 28

Kangmei Pharma Plans to Acquire Pharmaceutical Company for USD21 Million 29

Kangmei Pharma to Acquire Chongqing Ruitai Pharma for USD12.5 Million 30

Kangmei Pharma to Acquire 80% Stake in Guangdong Xin'ao Pharma for USD9 Million 31

Kangmei Pharma to Acquire Shenzhen Ieman Pharma for USD3.5 Million 32

Kangmei Pharmaceutical Co Ltd, Key Competitors 33

Kangmei Pharmaceutical Co Ltd, Key Employees 34

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022